Compass Group PLC (LON:CPG)

Verve Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	44,991	40,627	34,305	31,774	27,186	20,853
Market Cap Growth	9.46%	18.43%	7.97%	16.88%	30.37%	-37.20%
Enterprise Value	50,061	44,732	37,447	34,349	29,969	25,967
Last Close Price	26.51	23.50	19.24	17.05	14.20	10.89
PE Ratio	39.90	38.78	26.05	28.55	76.15	156.79
Forward PE	25.29	24.54	20.12	21.98	34.15	36.46
PS Ratio	1.33	1.30	1.10	1.25	1.52	1.05
PB Ratio	8.24	7.89	6.65	5.38	5.53	4.33
P/FCF Ratio	22.47	21.25	20.02	24.18	28.83	36.33
P/OCF Ratio	18.51	17.37	16.51	19.91	23.22	24.68
PEG Ratio	2.29	1.98	0.97	0.49	0.60	-
EV/Sales Ratio	1.48	1.43	1.21	1.35	1.67	1.30
EV/EBITDA Ratio	16.90	17.77	15.61	19.41	23.36	28.38
EV/EBIT Ratio	21.06	20.54	18.17	23.67	30.27	45.56
EV/FCF Ratio	25.00	23.39	21.85	26.14	31.78	45.24
Debt / Equity Ratio	1.01	0.87	0.86	0.85	0.91	0.98
Debt / EBITDA Ratio	1.88	1.67	1.74	2.61	3.11	4.39
Debt / FCF Ratio	2.75	2.35	2.60	3.83	4.75	8.24
Asset Turnover	1.84	1.83	1.71	1.52	1.21	1.42
Inventory Turnover	16.01	16.14	16.08	57.36	53.21	53.99
Quick Ratio	0.62	0.62	0.65	0.84	0.86	0.85
Current Ratio	0.69	0.74	0.75	0.95	0.95	0.94
Return on Equity (ROE)	21.66%	21.41%	23.87%	20.64%	7.34%	3.29%
Return on Assets (ROA)	7.97%	7.96%	7.09%	5.39%	4.18%	2.54%
Return on Capital (ROIC)	14.31%	14.79%	12.53%	8.92%	6.53%	4.24%
Return on Capital Employed (ROCE)	21.10%	20.40%	20.70%	12.40%	10.30%	5.60%
Earnings Yield	2.52%	2.58%	3.84%	3.50%	1.31%	0.64%
FCF Yield	4.45%	4.71%	5.00%	4.13%	3.47%	2.75%
Dividend Yield	1.76%	1.90%	2.24%	1.85%	0.99%	-
Payout Ratio	70.25%	68.59%	49.53%	37.56%	-	321.05%
Buyback Yield / Dilution	1.25%	2.18%	1.91%	0.34%	-7.60%	-4.54%
Total Shareholder Return	3.00%	4.08%	4.15%	2.18%	-6.61%	-4.54%

Updated Dec 18, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.